=== Comparator Extract 1 (Comparator) ===
100 was not specifically powered for overall and
progression-free survival outcomes, but it was powered for the primary
outcome. The committee acknowledged that the clinical evidence from
the CodeBreaK100 trial is relevant. An indirect comparison is appropriate because there are
to-head trials with comparator treatments, but this incre
uncertainty
3.4 There were no direct comparative data and no common trial arms for
anchored indirect treatment comparisons or network meta-analyses.
Therefore, the company used an unanchored indirect treatment
comparison (as recommended in the NICE Decision Support Unit
T

